logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

LianGong Wei: Net loss of 127 million yuan in the first half of 2025.

date
28/08/2025
Li Angwei Announcement, the operating income in the first half of 2025 was 1.66 billion yuan, a year-on-year increase of 14.18%. The net profit attributable to shareholders of the listed company was -127 million yuan, compared to -66.86 million yuan in the same period last year.
Latest
4 m ago
Guoji Precision (002046.SZ) released its first-half performance, with a net profit attributable to the parent company of 174 million yuan, a decrease of 1.69% year-on-year.
4 m ago
Guanxiang Technology (301213.SZ) released its performance for the first half of the year, with a net profit attributable to shareholders of 1.4267 million yuan, a decrease of 52.74%.
5 m ago
Chinese software company (600536.SH) released its semi-annual performance report, with a net loss attributable to shareholders of 74.53 million yuan.
6 m ago
Zhaoxin Technology Co., Ltd. (301000.SZ) released its first-half performance, with a net profit attributable to shareholders of 70.88 million yuan, a decrease of 8.57%.
6 m ago
Moderna, Pfizer, and Novavax's stock prices surged in a straight line as news came out that the FDA approved the vaccination of high-risk populations with the new COVID-19 vaccine.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.